Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Receptor Tyrosine Protein Kinase Targeted Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Receptor Tyrosine Protein Kinase Targeted Drugs by Country/Region, 2017, 2022 & 2028

2.2 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Type

2.2.1 Afatinib Dimaleate

2.2.2 Dacomitinib

2.2.3 Neratinib

2.2.4 Neucardin

2.2.5 Others

2.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type

2.3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Type (2017-2022)

2.4 Receptor Tyrosine Protein Kinase Targeted Drugs Segment by Application

2.4.1 Oncology

2.4.2 Cardiovascular

2.4.3 Central Nervous System

2.4.4 Others

2.5 Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application

2.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Application (2017-2022)

3 Global Receptor Tyrosine Protein Kinase Targeted Drugs by Company

3.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Breakdown Data by Company

3.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Company (2020-2022)

3.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Company (2020-2022)

3.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Company

3.4 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Product Location Distribution

3.4.2 Players Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Receptor Tyrosine Protein Kinase Targeted Drugs by Geographic Region

4.1 World Historic Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Revenue by Geographic Region

4.2 World Historic Receptor Tyrosine Protein Kinase Targeted Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Revenue by Country/Region

4.3 Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth

4.4 APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth

4.5 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth

4.6 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth

5 Americas

5.1 Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country

5.1.1 Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022)

5.1.2 Americas Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022)

5.2 Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type

5.3 Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region

6.1.1 APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2017-2022)

6.1.2 APAC Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2017-2022)

6.2 APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type

6.3 APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs by Country

7.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022)

7.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022)

7.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type

7.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs by Country

8.1.1 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type

8.3 Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

10.3 Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

10.4 Industry Chain Structure of Receptor Tyrosine Protein Kinase Targeted Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Receptor Tyrosine Protein Kinase Targeted Drugs Distributors

11.3 Receptor Tyrosine Protein Kinase Targeted Drugs Customer

12 World Forecast Review for Receptor Tyrosine Protein Kinase Targeted Drugs by Geographic Region

12.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Size Forecast by Region

12.1.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Region (2023-2028)

12.1.2 Global Receptor Tyrosine Protein Kinase Targeted Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Type

12.7 Global Receptor Tyrosine Protein Kinase Targeted Drugs Forecast by Application

13 Key Players Analysis

13.1 Aslan Pharmaceuticals Pte Ltd

13.1.1 Aslan Pharmaceuticals Pte Ltd Company Information

13.1.2 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.1.3 Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Aslan Pharmaceuticals Pte Ltd Main Business Overview

13.1.5 Aslan Pharmaceuticals Pte Ltd Latest Developments

13.2 Boehringer Ingelheim GmbH

13.2.1 Boehringer Ingelheim GmbH Company Information

13.2.2 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.2.3 Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Boehringer Ingelheim GmbH Main Business Overview

13.2.5 Boehringer Ingelheim GmbH Latest Developments

13.3 GamaMabs Pharma SA

13.3.1 GamaMabs Pharma SA Company Information

13.3.2 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.3.3 GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GamaMabs Pharma SA Main Business Overview

13.3.5 GamaMabs Pharma SA Latest Developments

13.4 Hanmi Pharmaceuticals Co Ltd

13.4.1 Hanmi Pharmaceuticals Co Ltd Company Information

13.4.2 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.4.3 Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Hanmi Pharmaceuticals Co Ltd Main Business Overview

13.4.5 Hanmi Pharmaceuticals Co Ltd Latest Developments

13.5 Jiangsu Kanion Pharmaceutical Co Ltd

13.5.1 Jiangsu Kanion Pharmaceutical Co Ltd Company Information

13.5.2 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.5.3 Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Jiangsu Kanion Pharmaceutical Co Ltd Main Business Overview

13.5.5 Jiangsu Kanion Pharmaceutical Co Ltd Latest Developments

13.6 Minerva Neurosciences Inc

13.6.1 Minerva Neurosciences Inc Company Information

13.6.2 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.6.3 Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Minerva Neurosciences Inc Main Business Overview

13.6.5 Minerva Neurosciences Inc Latest Developments

13.7 Pfizer Inc

13.7.1 Pfizer Inc Company Information

13.7.2 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.7.3 Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Pfizer Inc Main Business Overview

13.7.5 Pfizer Inc Latest Developments

13.8 Puma Biotechnology Inc

13.8.1 Puma Biotechnology Inc Company Information

13.8.2 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.8.3 Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Puma Biotechnology Inc Main Business Overview

13.8.5 Puma Biotechnology Inc Latest Developments

13.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd

13.9.1 Shanghai Fosun Pharmaceutical (Group) Co Ltd Company Information

13.9.2 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.9.3 Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Shanghai Fosun Pharmaceutical (Group) Co Ltd Main Business Overview

13.9.5 Shanghai Fosun Pharmaceutical (Group) Co Ltd Latest Developments

13.10 XuanZhu Pharma Co Ltd

13.10.1 XuanZhu Pharma Co Ltd Company Information

13.10.2 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.10.3 XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 XuanZhu Pharma Co Ltd Main Business Overview

13.10.5 XuanZhu Pharma Co Ltd Latest Developments

13.11 Zensun (Shanghai) Sci & Tech Co Ltd

13.11.1 Zensun (Shanghai) Sci & Tech Co Ltd Company Information

13.11.2 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

13.11.3 Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Zensun (Shanghai) Sci & Tech Co Ltd Main Business Overview

13.11.5 Zensun (Shanghai) Sci & Tech Co Ltd Latest Developments

14 Research Findings and Conclusion

Table 1. Receptor Tyrosine Protein Kinase Targeted Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Receptor Tyrosine Protein Kinase Targeted Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Afatinib Dimaleate

Table 4. Major Players of Dacomitinib

Table 5. Major Players of Neratinib

Table 6. Major Players of Neucardin

Table 7. Major Players of Others

Table 8. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Application (2017-2022)

Table 16. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Receptor Tyrosine Protein Kinase Targeted Drugs Producing Area Distribution and Sales Area

Table 24. Players Receptor Tyrosine Protein Kinase Targeted Drugs Products Offered

Table 25. Receptor Tyrosine Protein Kinase Targeted Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Receptor Tyrosine Protein Kinase Targeted Drugs

Table 69. Key Market Challenges & Risks of Receptor Tyrosine Protein Kinase Targeted Drugs

Table 70. Key Industry Trends of Receptor Tyrosine Protein Kinase Targeted Drugs

Table 71. Receptor Tyrosine Protein Kinase Targeted Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Receptor Tyrosine Protein Kinase Targeted Drugs Distributors List

Table 74. Receptor Tyrosine Protein Kinase Targeted Drugs Customer List

Table 75. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Forecast by Region

Table 77. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Aslan Pharmaceuticals Pte Ltd Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 97. Aslan Pharmaceuticals Pte Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Aslan Pharmaceuticals Pte Ltd Main Business

Table 99. Aslan Pharmaceuticals Pte Ltd Latest Developments

Table 100. Boehringer Ingelheim GmbH Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 102. Boehringer Ingelheim GmbH Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Boehringer Ingelheim GmbH Main Business

Table 104. Boehringer Ingelheim GmbH Latest Developments

Table 105. GamaMabs Pharma SA Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 107. GamaMabs Pharma SA Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. GamaMabs Pharma SA Main Business

Table 109. GamaMabs Pharma SA Latest Developments

Table 110. Hanmi Pharmaceuticals Co Ltd Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 112. Hanmi Pharmaceuticals Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Hanmi Pharmaceuticals Co Ltd Main Business

Table 114. Hanmi Pharmaceuticals Co Ltd Latest Developments

Table 115. Jiangsu Kanion Pharmaceutical Co Ltd Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 117. Jiangsu Kanion Pharmaceutical Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Jiangsu Kanion Pharmaceutical Co Ltd Main Business

Table 119. Jiangsu Kanion Pharmaceutical Co Ltd Latest Developments

Table 120. Minerva Neurosciences Inc Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 122. Minerva Neurosciences Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Minerva Neurosciences Inc Main Business

Table 124. Minerva Neurosciences Inc Latest Developments

Table 125. Pfizer Inc Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 127. Pfizer Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Pfizer Inc Main Business

Table 129. Pfizer Inc Latest Developments

Table 130. Puma Biotechnology Inc Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 132. Puma Biotechnology Inc Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Puma Biotechnology Inc Main Business

Table 134. Puma Biotechnology Inc Latest Developments

Table 135. Shanghai Fosun Pharmaceutical (Group) Co Ltd Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 137. Shanghai Fosun Pharmaceutical (Group) Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Shanghai Fosun Pharmaceutical (Group) Co Ltd Main Business

Table 139. Shanghai Fosun Pharmaceutical (Group) Co Ltd Latest Developments

Table 140. XuanZhu Pharma Co Ltd Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 142. XuanZhu Pharma Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. XuanZhu Pharma Co Ltd Main Business

Table 144. XuanZhu Pharma Co Ltd Latest Developments

Table 145. Zensun (Shanghai) Sci & Tech Co Ltd Basic Information, Receptor Tyrosine Protein Kinase Targeted Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Product Offered

Table 147. Zensun (Shanghai) Sci & Tech Co Ltd Receptor Tyrosine Protein Kinase Targeted Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Zensun (Shanghai) Sci & Tech Co Ltd Main Business

Table 149. Zensun (Shanghai) Sci & Tech Co Ltd Latest Developments

List of Figures

Figure 1. Picture of Receptor Tyrosine Protein Kinase Targeted Drugs

Figure 2. Receptor Tyrosine Protein Kinase Targeted Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Afatinib Dimaleate

Figure 10. Product Picture of Dacomitinib

Figure 11. Product Picture of Neratinib

Figure 12. Product Picture of Neucardin

Figure 13. Product Picture of Others

Figure 14. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Type in 2021

Figure 15. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Receptor Tyrosine Protein Kinase Targeted Drugs Consumed in Oncology

Figure 17. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market: Oncology (2017-2022) & (K Pcs)

Figure 18. Receptor Tyrosine Protein Kinase Targeted Drugs Consumed in Cardiovascular

Figure 19. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market: Cardiovascular (2017-2022) & (K Pcs)

Figure 20. Receptor Tyrosine Protein Kinase Targeted Drugs Consumed in Central Nervous System

Figure 21. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market: Central Nervous System (2017-2022) & (K Pcs)

Figure 22. Receptor Tyrosine Protein Kinase Targeted Drugs Consumed in Others

Figure 23. Global Receptor Tyrosine Protein Kinase Targeted Drugs Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Application (2017-2022)

Figure 25. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Application in 2021

Figure 26. Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Company in 2021

Figure 28. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Geographic Region in 2021

Figure 30. Global Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region (2017-2022)

Figure 31. Global Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country/Region in 2021

Figure 32. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2017-2022 (K Pcs)

Figure 33. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2017-2022 ($ Millions)

Figure 34. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2017-2022 (K Pcs)

Figure 35. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2017-2022 ($ Millions)

Figure 36. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2017-2022 (K Pcs)

Figure 37. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2021

Figure 41. Americas Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2021

Figure 42. United States Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Region in 2021

Figure 47. APAC Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Regions in 2021

Figure 48. China Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2021

Figure 55. Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2021

Figure 56. Germany Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Country in 2021

Figure 63. Egypt Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs in 2021

Figure 69. Manufacturing Process Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs

Figure 70. Industry Chain Structure of Receptor Tyrosine Protein Kinase Targeted Drugs

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles